Meros Investment Management LP Buys Shares of 468,934 InfuSystem Holdings, Inc. $INFU

Meros Investment Management LP bought a new stake in shares of InfuSystem Holdings, Inc. (NYSE:INFUFree Report) in the 2nd quarter, Holdings Channel reports. The firm bought 468,934 shares of the company’s stock, valued at approximately $4,525,213,000.

A number of other hedge funds have also recently made changes to their positions in INFU. Hsbc Holdings PLC bought a new position in InfuSystem during the 2nd quarter valued at approximately $276,000. Ancora Advisors LLC bought a new stake in InfuSystem in the second quarter worth $778,000. Expect Equity LLC bought a new stake in InfuSystem in the second quarter worth $1,784,000. Canada Pension Plan Investment Board purchased a new stake in shares of InfuSystem in the second quarter worth $303,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of InfuSystem in the second quarter worth $803,000. 71.13% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, B. Riley Financial reaffirmed a “buy” rating and issued a $20.00 price target (up from $12.00) on shares of InfuSystem in a research report on Wednesday, August 5th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, InfuSystem currently has a consensus rating of “Moderate Buy” and an average target price of $16.67.

View Our Latest Stock Report on INFU

InfuSystem Trading Up 0.6%

NYSE:INFU opened at $12.02 on Wednesday. The stock has a market cap of $242.59 million, a price-to-earnings ratio of 200.37 and a beta of 1.42. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The company’s 50 day moving average price is $10.30 and its 200-day moving average price is $9.59. InfuSystem Holdings, Inc. has a 52 week low of $7.29 and a 52 week high of $12.97.

InfuSystem announced that its Board of Directors has approved a stock repurchase plan on Tuesday, May 19th that allows the company to buyback $20.00 million in outstanding shares. This buyback authorization allows the company to repurchase up to 10.2% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s management believes its stock is undervalued.

About InfuSystem

(Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

See Also

Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. (NYSE:INFUFree Report).

Institutional Ownership by Quarter for InfuSystem (NYSE:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.